Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,176 | 25,987 | 93,088 | 106,278 | 200,598 |
| Marketable Securities | 17,466 | 25,884 | 149,877 | 264,984 | 300,255 |
| Receivables | 1,482 | 34,108 | 40,221 | 986 | 1,250 |
| Inventories | 10,655 | 9,706 | 1,586 | N/A | N/A |
| Other current assets | 10,115 | 6,184 | 10,308 | 0 | 0 |
| TOTAL | $64,894 | $101,869 | $295,080 | $384,621 | $523,273 |
| Non-Current Assets | |||||
| PPE Net | 1,294 | 3,856 | 6,300 | 53,780 | 50,517 |
| Other Non-Current Assets | 42,910 | 59,779 | 75,040 | 29,726 | 14,330 |
| TOTAL | $44,204 | $63,635 | $81,340 | $83,506 | $64,847 |
| Total Assets | $109,098 | $165,504 | $376,420 | $468,127 | $588,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,367 | 3,684 | 6,871 | 17,368 | 7,118 |
| Accrued Expenses | 6,589 | 11,519 | 17,659 | 25,150 | 20,458 |
| Other current liabilities | 20,542 | 31,826 | 21,394 | 9,057 | 6,057 |
| TOTAL | $134,574 | $142,226 | $78,916 | $105,786 | $82,901 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 95,092 | 77,833 | 8,000 | 40,760 | 33,455 |
| Other Non-Current Liabilities | 71,807 | 84,947 | 93,864 | 27,019 | 15,085 |
| TOTAL | $71,807 | $122,509 | $170,864 | $82,727 | $42,880 |
| Total Liabilities | $206,381 | $264,735 | $249,780 | $188,513 | $125,781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,859 | 4,774 | 3,837 | 3,724 | 3,345 |
| Common Shares | 1 | N/A | 10 | 9 | 8 |
| Retained earnings | -2,054,553 | -1,969,150 | -1,693,024 | -1,464,722 | -1,124,581 |
| Other shareholders' equity | 8 | -204 | -2,067 | -368 | 296 |
| TOTAL | $-97,283 | $-99,231 | $126,640 | $279,614 | $462,339 |
| Total Liabilities And Equity | $109,098 | $165,504 | $376,420 | $468,127 | $588,120 |